Zobrazeno 1 - 5
of 5
pro vyhledávání: '"D.M. Chudakov"'
Autor:
S.V. Krasik, E.A. Bryushkova, G.V. Sharonov, D.S. Myalik, E.V. Shurganova, D.V. Komarov, I.A. Shagina, P.S. Shpudeiko, M.A. Turchaninova, M.T. Vakhitova, I.V. Samoylenko, D.T. Marinov, LV Demidov, V.E. Zagainov, D.M. Chudakov, E.O. Serebrovskaya
The current understanding of humoral immune response in cancer patients suggests that tumors may be infiltrated with diffuse B cells of extra-tumoral origin or develop organized lymphoid structures, where somatic hypermutation and antigen-driven sele
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::48b70eada782c834a3c08959532bf4eb
https://doi.org/10.1101/2023.04.16.537028
https://doi.org/10.1101/2023.04.16.537028
Autor:
E.A. Bryushkova, V.D. Skatova, Z.Y. Mutovina, A.I. Zagrebneva, D.S. Fomina, T.S. Kruglova, A. Akopyan, I.D. Strazhesko, S. Lukyanov, O.N. Tkacheva, M.A. Lysenko, D.M. Chudakov
BackgroundThe aim of the study was to assess inflammatory markers and clinical outcomes in adult patients admitted to hospital with mild-to-moderate COVID-19 and treated with targeted immunosuppressive therapy using anti-IL-17A (netakimab), anti-IL-6
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::cc8e63eb5e973a61618ef225e296a378
https://doi.org/10.1101/2022.03.31.22269942
https://doi.org/10.1101/2022.03.31.22269942
Autor:
M.M. Goncharov, E.A. Bryushkova, N.I. Sharayev, V.D. Skatova, A.M. Baryshnikova, G.V. Sharonov, I.V. Samoylenko, L.V. Demidov, D.M. Chudakov, E.O. Serebrovskaya
Adoptive T cell transfer (ACT) is a promising approach to cancer immunotherapy, but its efficiency fundamentally depends on the extent of tumor-specific T-cell enrichment within the graft. This can be estimated via activation with identifiable neoant
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::971a6655901abd44245364f4c86f4d92
https://doi.org/10.1101/2022.01.30.478375
https://doi.org/10.1101/2022.01.30.478375
Autor:
G.V. Sharonov, A.V. Izosimova, Elena V. Zagaynova, L. Barbashova, D.V. Yuzhakova, D.M. Chudakov
Publikováno v:
Annals of Oncology. 30:xi12-xi13
Background One of most promising strategies for cancer immunotherapy is adoptive T cell therapy (ACT). In the frame of this approach, tumor-specific lymphocytes (TSL) are infused into patients to recognize and destroy tumor cells. The key step of ACT
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::224eefb0d8373b335c02f8d763f09f8b
https://doi.org/10.1093/annonc/mdz448.003
https://doi.org/10.1093/annonc/mdz448.003
Autor:
D.M. Chudakov, Shannon O'Leary, M.L. Quillin, S.J. Remington, K. Kallio, Xiaokun Shu, David M. Anstrom
Publikováno v:
Biochemistry. 44(15)
When the nonfluorescent chromoprotein asFP595 from Anemonia sulcata is subjected to sufficiently intense illumination near the absorbance maximum (lambda(abs)(max) = 568 nm), it undergoes a remarkable transition, termed "kindling", to a long-lived fl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::954e4baba201723e6f3329a429981f42
https://pubmed.ncbi.nlm.nih.gov/15823036
https://pubmed.ncbi.nlm.nih.gov/15823036